Proteomics receives $1.1 million in R&D tax incentive

Earlier from Proteomics International Laboratories

• Completion of Placement and Appendix 2ANov 1, 2020
• September 2020 Quarterly Activities Report and Appendix 4COct 27, 2020
• Proteomics International raises $6m in successful PlacementOct 22, 2020
• First distribution agreement for PromarkerD immunoassayOct 15, 2020
• Partnership with QIMR Berghofer targets oesophageal cancerOct 8, 2020

Later from Proteomics International Laboratories

• PromarkerD clinical assay performance results publishedNov 4, 2020
• Middle East is next market for PromarkerD immunoassay testNov 11, 2020
• AGM Investor PresentationNov 25, 2020
• December 2020 Quarterly Activities Report and Appendix 4CJan 27, 2021
• Proteomics International seeks FDA approval for PromarkerDFeb 7, 2021